Initial experience with brolucizumab for neovascular age-related macular degeneration (nAMD) in India - Multicentric, real-world study.

Singh DV, Agarwal A, Goyal A, Shroff D, Singh J, Kumar P, Reddy RR, Venkatesh R, Narnaware S, Joshi S, Singh DV, Narula R, Joshi A, Agarwal A, Goyal A, Gupta C, Shroff D, Anantharaman G, Singh J, Kumar P, Bawankule P, Reddy RR, Jain R, Venkatesh R, Tiwari R, Sugumar S, Gupta SR, Narnaware S, Joshi S, Choudhary SP, Delhi Retina Forum Study Group

Open source

DOI: 10.4103/ijo.ijo_757_24
Published: 2024 Dec 1
Container: Indian journal of ophthalmology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.4103/ijo.ijo_757_24,
  title = {Initial experience with brolucizumab for neovascular age-related macular degeneration (nAMD) in India - Multicentric, real-world study.},
  author = {Singh DV and Agarwal A and Goyal A and Shroff D and Singh J and Kumar P and Reddy RR and Venkatesh R and Narnaware S and Joshi S and Singh DV and Narula R and Joshi A and Agarwal A and Goyal A and Gupta C and Shroff D and Anantharaman G and Singh J and Kumar P and Bawankule P and Reddy RR and Jain R and Venkatesh R and Tiwari R and Sugumar S and Gupta SR and Narnaware S and Joshi S and Choudhary SP and Delhi Retina Forum Study Group},
  year = {2024},
  journal = {Indian journal of ophthalmology},
  doi = {10.4103/ijo.ijo_757_24},
  url = {https://doi.org/10.4103/ijo.ijo_757_24}
}

RIS

TY  - JOUR
TI  - Initial experience with brolucizumab for neovascular age-related macular degeneration (nAMD) in India - Multicentric, real-world study.
AU  - Singh DV
AU  - Agarwal A
AU  - Goyal A
AU  - Shroff D
AU  - Singh J
AU  - Kumar P
AU  - Reddy RR
AU  - Venkatesh R
AU  - Narnaware S
AU  - Joshi S
AU  - Singh DV
AU  - Narula R
AU  - Joshi A
AU  - Agarwal A
AU  - Goyal A
AU  - Gupta C
AU  - Shroff D
AU  - Anantharaman G
AU  - Singh J
AU  - Kumar P
AU  - Bawankule P
AU  - Reddy RR
AU  - Jain R
AU  - Venkatesh R
AU  - Tiwari R
AU  - Sugumar S
AU  - Gupta SR
AU  - Narnaware S
AU  - Joshi S
AU  - Choudhary SP
AU  - Delhi Retina Forum Study Group
PY  - 2024
JO  - Indian journal of ophthalmology
DO  - 10.4103/ijo.ijo_757_24
UR  - https://doi.org/10.4103/ijo.ijo_757_24
ER  -

APA

DV, S., A, A., A, G., D, S., J, S., P, K., RR, R., R, V., S, N., S, J., DV, S., R, N., A, J., A, A., A, G., C, G., D, S., G, A., J, S., P, K., P, B., RR, R., R, J., R, V., R, T., S, S., SR, G., S, N., S, J., SP, C., & Group, D. R. F. S. (2024). Initial experience with brolucizumab for neovascular age-related macular degeneration (nAMD) in India - Multicentric, real-world study.. Indian journal of ophthalmology. https://doi.org/10.4103/ijo.ijo_757_24

Source records

pubmed · retrieved 2026-09-26T00:14:31.177Z